Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study

URN to cite this document:: urn:nbn:de:bvb:355-epub-580378
DOI to cite this document:: 10.5283/epub.58037

Schneider, Markus P. ; Schmid, Matthias ; Nadal, Jennifer ; Krane, Vera ; Saritas, Turgay ; Busch, Martin ; Schultheiss, Ulla T. ; Meiselbach, Heike ; Friedrich, Nele ; Nauck, Matthias ; Floege, Jürgen ; Kronenberg, Florian ; Wanner, Christoph ; Eckardt, Kai-Uwe ; Oefner, Peter J. ; Gronwald, Wolfram

License: Creative Commons Attribution Non-commercial No Derivatives 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 08 Apr 2024 07:08

Alternative links to fulltext:Pubmed DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Copeptin and Midrange pro-atrial natriuretic peptide (MR-pro-ANP) are associated with outcomes independently of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in patients with heart failure (HF). The value of these markers in patients with chronic kidney disease (CKD) has not been studied.

Owner only: item control page

Download Statistics